Navigation Links
Entelos Expands Executive Team
Date:2/5/2013

San Mateo, CA (PRWEB) February 05, 2013

Entelos Holding Corp. (“Entelos” or the “Company”), a premier provider of physiological system modeling and services that help pharmaceutical and consumer product companies predict better paths to success in their development process, today announced that Dr. Mike Davies and Dr. Dominic John have joined the senior management team of the Company as Global Vice President of Sales and Vice President of Marketing, effective immediately.

“It is an indication of the opportunity ahead that we have been able to attract such seasoned and experienced executives who will, in turn, help us execute on the opportunity.” said Shawn O’Connor, President and Chief Executive Officer of Entelos. “With more and more companies looking to project efficient outcomes, study less and outsource more, Entelos is ideally placed to address the market need with leading modeling technology, physiological models and experienced scientific services. Mike and Dominic both bring to Entelos over 35 years of experience leading successful scientific companies in our market space. Their contributions will be invaluable to our future investment and growth to deliver market leading strategic partnerships and predictive therapeutic solutions.”

Dr. Davies has had more than 20 years of experience providing a robust background in scientific research and a track record of strong commercial leadership. Prior to joining Entelos, Dr. Davies was Vice President Global Sales of the Health Sciences GBU at Oracle Corporation after holding senior positions in Sales and Global Strategic Partnerships over 10 years at Phase Forward, Inc. and prior at Parke-Davis, a division of Warner Lambert. Dr. Davies scientific background is based in physiology and pharmacology having completed 3 years post-doctoral work at the University of Rochester.

Dr. John has had more than 15 years in research and scientific software product management and marketing having held senior positions in MDL Information Systems, Symyx Technologies and Accelrys Inc. Prior to joining Entelos, Dr. John was Director of Product Marketing at Accelrys, a $160M scientific software company. Dr. John has a scientific background that includes modeling, biochemistry and toxicology.

Entelos is a physiological modeling and simulation software and services company delivering predictive technologies reducing risk, time, and cost of product development for pharmaceutical, biotechnology, nutrition and consumer products companies. The Company's PhysioLab® systems biology models generate virtual drug and patient populations providing qualitative and quantitative insight and understanding to develop safer and more effective drugs and consumer products. Entelos’ understanding of population variability has significant application to the emerging field of personalized medicine and market segmentation. The Company is headquartered in San Mateo, California. For more information, please visit http://www.entelos.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10386823.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Blackall Mechanical, Inc. Expands Project Department to Better Serve Customers in North and South Texas
2. Popular Medical Tourism Portal, myMEDholiday.com, Expands Its Functionality by Adding RSS Feeds
3. Zinga Frozen Yogurt Expands Into Southern California in a Big Way
4. US Drug Watchdog Now Expands Their DePuy Pinnacle All Metal Hip Implant Initiative with Emphasis on Senior Citizens and Getting a Blood Test for Cobalt and Chromium
5. Henry Ford Expands Use of Apollo EPMM® to Provide Clinical Multimedia Management Solutions Enterprise-wide
6. Kitsilano Kitty's Closet Online Boutique Expands to Include Luxury Consignment!
7. Ambiance Expands Romantic Technology Leadership with New High-Tech Toy
8. Oncologist expands HPV research to anal cancer
9. Mesothelioma Victims Center Expands Its Best Mesothelioma Law Firms Get The Best Results Initiative Because Victims Of Mesothelioma Deserve The Best Results-Compensation
10. The Leader In Healthy Chocolate; Marketing Xocolate International Corporation (MXI Corp) Expands Their Operations To Hong Kong, Xocai Now Available On Five Continents
11. PayerFusion Expands Reach of Health Plan Administration Services Across the USA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the ... (United States, China, Japan, Brazil, United Kingdom, Germany, France, ... Surgical Procedure Volumes: ... provides surgical procedure volume data in a geographic context. ... analysis of growth drivers and inhibitors, including world population ...
(Date:6/23/2016)... , June 23, 2016 ... but it continues to present great opportunities to investors. ... for today: Intrexon Corp. (NYSE: XON ), ... Pharmaceuticals Inc. (NASDAQ: ARNA ), and Regeneron ... about these stocks and receive your complimentary trade alerts ...
(Date:6/23/2016)... SAN DIEGO , June 23, 2016 /PRNewswire/ ... advancing programs that address medical conditions resulting from ... that it has appointed Greg Doyle ... member of Leading BioSciences, executive management team and ... officer and chief financial officer. He will provide ...
Breaking Medicine Technology: